Quick Search:

uzh logo
Browse by:
bullet
bullet
bullet
bullet

Zurich Open Repository and Archive

Permanent URL to this publication: http://dx.doi.org/10.5167/uzh-58134

Wong, W. Wei-Lynn; Clendening, J W; Martirosyan, A; Boutros, P C; Bros, C; Khosravi, F; Jurisica, I; Stewart, A K; Bergsagel, P L; Penn, L Z (2007). Determinants of sensitivity to lovastatin-induced apoptosis in multiple myeloma. Molecular Cancer Therapeutics, 6(6):1886-1897.

[img]Published Version (English)
PDF - Registered users only
514kB

View at publisher

Abstract

Statins, commonly used to treat hypercholesterolemia,
have been shown to trigger tumor-specific apoptosis in
certain cancers, including multiple myeloma (MM), a
plasma cell malignancy with poor prognosis. In this article,
we show that of a panel of 17 genetically distinct MM cell
lines, half were sensitive to statin-induced apoptosis and,
despite pharmacodynamic evidence of drug uptake and
activity, the remainder were insensitive. Sensitive cells
were rescued from lovastatin-induced apoptosis by
mevalonate, geranylgeranyl PPi, and partially by farnesyl
PPi, highlighting the importance of isoprenylation. Expression
profiling revealed that Rho GTPase mRNAs were
differentially expressed upon lovastatin exposure in
sensitive cells, yet ectopic expression of constitutively
active Rho or Ras proteins was insufficient to alter
sensitivity to lovastatin-induced apoptosis. This suggests
that sensitivity involves more than one isoprenylated
protein and that statins trigger apoptosis by blocking
many signaling cascades, directly or indirectly deregulated by the oncogenic lesions of the tumor cell. Indeed, clustering
on the basis of genetic abnormalities was shown to be
significantly associated with sensitivity (P = 0.003).
These results suggest that statins may be a useful
molecular targeted therapy in the treatment of a subset
of MM.

Citations

23 citations in Web of Science®
24 citations in Scopus®
Google Scholar™

Altmetrics

Downloads

1 download since deposited on 15 Jun 2012
0 downloads since 12 months

Detailed statistics

Additional indexing

Item Type:Journal Article, refereed, original work
Communities & Collections:04 Faculty of Medicine > University Hospital Zurich > Institute of Experimental Immunology
DDC:570 Life sciences; biology
610 Medicine & health
Language:English
Date:2007
Deposited On:15 Jun 2012 15:49
Last Modified:12 Dec 2013 14:36
Publisher:American Association for Cancer Research, Inc.
ISSN:1535-7163 (P) 1538-8514 (E)
Free access at:Publisher DOI. An embargo period may apply.
Publisher DOI:10.1158/1535-7163.MCT-06-0745
PubMed ID:17575117

Users (please log in): suggest update or correction for this item

Repository Staff Only: item control page